We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+13.29%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$47.2B
AUM Growth
+$8.08B
Cap. Flow
+$2.33B
Cap. Flow %
4.95%
Top 10 Hldgs %
35.89%
Holding
5,834
New
1,032
Increased
1,743
Reduced
1,554
Closed
961

Sector Composition

Rank Sector Weight
1 Technology 2.27%
2 Financials 2.09%
3 Healthcare 1.72%
4 Consumer Discretionary 1.48%
5 Industrials 1.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBW icon
4176
PUT
Build-A-Bear
BBW
$434M
$59.8K ﹤0.01%
2,600
LMND icon
4177
PUT
Lemonade
LMND
$3.75B
$59.7K ﹤0.01%
3,700
-18,400
-83% -$277K
PLAB icon
4178
PUT
Photronics
PLAB
$1.78B
$59.6K ﹤0.01%
+1,900
New +$42.3K
ACVA icon
4179
PUT
ACV Auctions
ACVA
$1.32B
$59.1K ﹤0.01%
3,900
+1,700
+77% +$24.9K
TWST icon
4180
PUT
Twist Bioscience
TWST
$5.61B
$59K ﹤0.01%
1,600
-7,700
-83% -$178K
TIGR
4181
CALL
UP Fintech Holding
TIGR
$868M
$58.3K ﹤0.01%
+13,200
New +$60.9K
CVIIW
4182
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$58.1K ﹤0.01%
446,703
+30,663
+7% +$5.09K
EPD icon
4183
PUT
Enterprise Products Partners
EPD
$82.1B
$58K ﹤0.01%
2,200
FLGT icon
4184
CALL
Fulgent Genetics
FLGT
$464M
$57.8K ﹤0.01%
+2,000
New +$53.5K
RBOT.WS
4185
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$57.5K ﹤0.01%
1,915,431
-110,695
-5% -$4.15K
APLT
4186
DELISTED
Applied Therapeutics
APLT
$57K ﹤0.01%
17,000
-122,381
-88% -$305K
NTGR icon
4187
CALL
NETGEAR
NTGR
$647M
$56.9K ﹤0.01%
+3,900
New +$50.5K
EGHT icon
4188
8x8 Inc
EGHT
$264M
$56.7K ﹤0.01%
15,000
-28,941
-66% -$85.9K
UIS icon
4189
CALL
Unisys
UIS
$219M
$56.2K ﹤0.01%
+10,000
New +$42.5K
SYRA
4190
DELISTED
Syra Health Corp. Class A Common Stock
SYRA
$56K ﹤0.01%
54,910
-41,435
-43% -$63.9K
MCRB icon
4191
Seres Therapeutics
MCRB
$46.4M
$55.9K ﹤0.01%
1,997
-3,091
-61% -$81.2K
EVBG
4192
PUT
DELISTED
Everbridge, Inc. Common Stock
EVBG
$55.9K ﹤0.01%
+2,300
New +$49.6K
ZTR
4193
Virtus Total Return Fund
ZTR
$342M
$55.9K ﹤0.01%
10,140
-115,143
-92% -$587K
ZUMZ icon
4194
Zumiez
ZUMZ
$331M
$55.6K ﹤0.01%
2,736
-18,639
-87% -$334K
BHVN icon
4195
PUT
Biohaven
BHVN
$2.02B
$55.6K ﹤0.01%
1,300
-2,100
-62% -$65.3K
JSPRW icon
4196
Japer Therapeutics Warrants
JSPRW
$55.6K ﹤0.01%
695,014
-5,422
-0.8% -$450
SIGA icon
4197
CALL
SIGA Technologies
SIGA
$227M
$55.4K ﹤0.01%
+9,900
New +$53K
CAPTW
4198
DELISTED
Captivision Inc Warrant
CAPTW
$55.4K ﹤0.01%
+692,320
New +$64K
MCB icon
4199
CALL
Metropolitan Bank Holding Corp
MCB
$1.15B
$55.4K ﹤0.01%
1,000
-100
-9% -$3.95K
UEC icon
4200
CALL
Uranium Energy
UEC
$4.67B
$55K ﹤0.01%
+8,600
New +$51.3K

Similar funds

Walleye Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Walleye Capital held 5,834 positions worth $47.2B, up 21% from $39.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Walleye Capital deployed $2.33B of net new capital in Q4 2023, opening 1,032 new positions and adding to 1,743 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.

By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 2.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $59.4M trimmed.

  • Walleye Capital's largest Q4 2023 buy was State Street SPDR S&P 500 ETF Trust: 843,344 shares worth $401M.
  • Walleye Capital added most to Lam Research in Q4 2023, an estimated $51.4M increase.
  • Walleye Capital's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $59.4M.
  • Walleye Capital fully exited VMware, Inc in Q4 2023, selling an estimated $57.2M.
  • Walleye Capital's ten largest holdings make up 36% of its $47.2B portfolio in Q4 2023.
  • Walleye Capital opened 1,032 new positions and closed 961 in Q4 2023.
  • Walleye Capital's portfolio value rose 21% quarter-over-quarter to $47.2B.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.